Johnson & Johnson

By Laura Lovett July 17, 2018
VitalConnect and physIQ are teaming up with the Haga Teaching Hospital in the Netherlands to conduct a study on how wearable biosensors and artificial intelligence can augment care for cancer patients undergoing treatment. Specifically, the study — which is funded by Johnson & Johnson subsidiary Janssen Pharmaceuticals — is looking to see how the technology can detect adverse events in cancer...
By Jonah Comstock July 17, 2018
As Johnson & Johnson continues to move out of the diabetes business, the company has sold its Calibra product (marketed as OneTouch Via, but never launched) to CeQur, a 10-year-old company working on a similar insulin-delivery wearable. Terms of the deal were not disclosed, but CeQur has acquired an exclusive worldwide license for the technology. “They’re divesting out of the diabetes market...
By Laura Lovett April 25, 2018
Like almost any field in the healthcare industry pharma wants to get in on the latest technology trends. Recently big pharma has been looking to artificial intelligence as another tool to help facilitate drug research and help the company progress.  At the World Medical Innovation Forum in Boston on April 24, a panel of pharma leaders discussed the future of AI in the industry.  “It's quite top...
By Jonah Comstock March 16, 2018
Platinum Equity, a Los Angeles-based global investment firm focused on mergers, acquisitions, and operations, has made a binding offer to acquire Johnson & Johnsons' Chesterbrook, Pennsylvania and Zug, Switzerland-based LifeScan business, which sells the OneTouch line of connected and non-connected glucometers. Platinum Equity will pay $2.1 billion for the business, which reported $1.5...
By Dave Muoio November 13, 2017
Humana and Johnson & Johnson have each announced a new challenge competition for digital health students and entrepreneurs. The former seeks novel approaches to easy and understandable EHR management with a focus on Medicare-compatibility, and will award up to $10,000. The latter is offering up to $50,000 for new skin care strategies potentially incorporating tracking devices, adherence...
By Dave Muoio November 6, 2017
Johnson & Johnson has announced a suite of digital tools designed for patients preparing to undergo or recovering from knee, hip, and weight loss surgery. The Health Partner platform consists of three tools — a website, mobile app, and care portal — all of which are interconnected to provide patients adaptive education and surgery support. Along with offering providers a means to interact...
By Jonah Comstock October 23, 2017
Johnson & Johnson subsidiary Ethicon and Touch Surgery have launched a Virtual Residency Program for surgery students, a new use case for the simulated surgery app launched last fall. The program pre-launched in April and currently has 75 organizations enrolled. "Ethicon is committed to supporting the continuing educational needs of residents and surgeons by providing access to innovative...
By Jonah Comstock October 11, 2017
Janssen Research and Development, a Johnson & Johnson subsidiary, will launch the first clinical trial to use its iSTEP technology toolset, which employs smart blisterpacks and a patient-facing smartphone app, by the end of the year. iSTEP, which stands for Integrated Smart Trial and Engagement Platform, has been under development at Janssen for five years. “The mission of Janssen as an...
By Jonah Comstock September 26, 2017
Just two months after announcing the applications for its pre-certification program pilot, the FDA has announced the nine companies that will be participating. The list includes major tech companies Apple and Samsung; health tech companies Verily, Pear Therapeutics, Tidepool, and Phosphorus; pharmaceutical companies Roche and Johnson & Johnson; and Fitbit — an interesting inclusion insofaras...
By Jonah Comstock June 28, 2017
DayTwo, an Israeli startup focused on delivering insights to consumers based on their gut microbiome, has raised $12 million from an impressive suite of investors including Johnson & Johnson Innovation and the Mayo Clinic. Seventure Partners' Health for Life Capital Fund also contributed along with private investors including cofounder Marius Nacht. The startup, which has raised $17 million...